Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions

P. G. Natali, M. R. Nicotra, F. Di Filippo, A. Bigotti

Research output: Contribution to journalArticle

Abstract

In vitro studies have demonstrated that fibronectin (FN) can deliver a mitogenic signal to quiescent human melanoma cells and that the α51-integrin receptor mediates this stimulus. In view of this finding we have analysed the in vivo expression of FN, and of ED-A and ED-B FN isoforms, in benign and malignant lesions of melanocyte origin. In the same specimens the expression of fibronectin integrin receptors was evaluated. The results demonstrate that, while detection of FN does not correlate with transformation and tumour progression, the expression of the two isoforms is associated with transformation and that only the ED-A variant is found in metastases. Integrin phenotyping disclosed that α31 expression is associated with tumour progression, α(v)/β3 is a marker of transformation, α4 is rarely expressed and α5 is expressed by about 50% and 30% of the primary and metastatic lesions respectively. Taken together, the results of this study demonstrate that transformation and tumour progression of the melanocyte lineage are associated with modulation of expression of FN isoforms and FN integrin receptors. Furthermore, the expression of α5-integrin in a considerable percentage of primary and metastatic lesions indicates that FN may deliver a proliferative stimulus to melanoma cells in vivo.

Original languageEnglish
Pages (from-to)1243-1247
Number of pages5
JournalBritish Journal of Cancer
Volume71
Issue number6
Publication statusPublished - 1995

Fingerprint

Fibronectins
Integrins
Protein Isoforms
Fibronectin Receptors
Melanocytes
Melanoma
Neoplasms
Neoplasm Metastasis

Keywords

  • Fibronectin
  • Integrin
  • Melanoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Natali, P. G., Nicotra, M. R., Di Filippo, F., & Bigotti, A. (1995). Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. British Journal of Cancer, 71(6), 1243-1247.

Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. / Natali, P. G.; Nicotra, M. R.; Di Filippo, F.; Bigotti, A.

In: British Journal of Cancer, Vol. 71, No. 6, 1995, p. 1243-1247.

Research output: Contribution to journalArticle

Natali, PG, Nicotra, MR, Di Filippo, F & Bigotti, A 1995, 'Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions', British Journal of Cancer, vol. 71, no. 6, pp. 1243-1247.
Natali, P. G. ; Nicotra, M. R. ; Di Filippo, F. ; Bigotti, A. / Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions. In: British Journal of Cancer. 1995 ; Vol. 71, No. 6. pp. 1243-1247.
@article{b0becb9eff3b4a4f902bc84472fb890a,
title = "Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions",
abstract = "In vitro studies have demonstrated that fibronectin (FN) can deliver a mitogenic signal to quiescent human melanoma cells and that the α5/β1-integrin receptor mediates this stimulus. In view of this finding we have analysed the in vivo expression of FN, and of ED-A and ED-B FN isoforms, in benign and malignant lesions of melanocyte origin. In the same specimens the expression of fibronectin integrin receptors was evaluated. The results demonstrate that, while detection of FN does not correlate with transformation and tumour progression, the expression of the two isoforms is associated with transformation and that only the ED-A variant is found in metastases. Integrin phenotyping disclosed that α3/β1 expression is associated with tumour progression, α(v)/β3 is a marker of transformation, α4 is rarely expressed and α5 is expressed by about 50{\%} and 30{\%} of the primary and metastatic lesions respectively. Taken together, the results of this study demonstrate that transformation and tumour progression of the melanocyte lineage are associated with modulation of expression of FN isoforms and FN integrin receptors. Furthermore, the expression of α5-integrin in a considerable percentage of primary and metastatic lesions indicates that FN may deliver a proliferative stimulus to melanoma cells in vivo.",
keywords = "Fibronectin, Integrin, Melanoma",
author = "Natali, {P. G.} and Nicotra, {M. R.} and {Di Filippo}, F. and A. Bigotti",
year = "1995",
language = "English",
volume = "71",
pages = "1243--1247",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Expression of fibronectin, fibronectin isoforms and integrin receptors in melanocytic lesions

AU - Natali, P. G.

AU - Nicotra, M. R.

AU - Di Filippo, F.

AU - Bigotti, A.

PY - 1995

Y1 - 1995

N2 - In vitro studies have demonstrated that fibronectin (FN) can deliver a mitogenic signal to quiescent human melanoma cells and that the α5/β1-integrin receptor mediates this stimulus. In view of this finding we have analysed the in vivo expression of FN, and of ED-A and ED-B FN isoforms, in benign and malignant lesions of melanocyte origin. In the same specimens the expression of fibronectin integrin receptors was evaluated. The results demonstrate that, while detection of FN does not correlate with transformation and tumour progression, the expression of the two isoforms is associated with transformation and that only the ED-A variant is found in metastases. Integrin phenotyping disclosed that α3/β1 expression is associated with tumour progression, α(v)/β3 is a marker of transformation, α4 is rarely expressed and α5 is expressed by about 50% and 30% of the primary and metastatic lesions respectively. Taken together, the results of this study demonstrate that transformation and tumour progression of the melanocyte lineage are associated with modulation of expression of FN isoforms and FN integrin receptors. Furthermore, the expression of α5-integrin in a considerable percentage of primary and metastatic lesions indicates that FN may deliver a proliferative stimulus to melanoma cells in vivo.

AB - In vitro studies have demonstrated that fibronectin (FN) can deliver a mitogenic signal to quiescent human melanoma cells and that the α5/β1-integrin receptor mediates this stimulus. In view of this finding we have analysed the in vivo expression of FN, and of ED-A and ED-B FN isoforms, in benign and malignant lesions of melanocyte origin. In the same specimens the expression of fibronectin integrin receptors was evaluated. The results demonstrate that, while detection of FN does not correlate with transformation and tumour progression, the expression of the two isoforms is associated with transformation and that only the ED-A variant is found in metastases. Integrin phenotyping disclosed that α3/β1 expression is associated with tumour progression, α(v)/β3 is a marker of transformation, α4 is rarely expressed and α5 is expressed by about 50% and 30% of the primary and metastatic lesions respectively. Taken together, the results of this study demonstrate that transformation and tumour progression of the melanocyte lineage are associated with modulation of expression of FN isoforms and FN integrin receptors. Furthermore, the expression of α5-integrin in a considerable percentage of primary and metastatic lesions indicates that FN may deliver a proliferative stimulus to melanoma cells in vivo.

KW - Fibronectin

KW - Integrin

KW - Melanoma

UR - http://www.scopus.com/inward/record.url?scp=0029000256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029000256&partnerID=8YFLogxK

M3 - Article

C2 - 7779718

AN - SCOPUS:0029000256

VL - 71

SP - 1243

EP - 1247

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 6

ER -